EE9600050A - Meetod kinoloone sisaldavate oraalsete kompositsioonide valmistamiseks ja tablett kinoloonide oraalseks manustamiseks - Google Patents

Meetod kinoloone sisaldavate oraalsete kompositsioonide valmistamiseks ja tablett kinoloonide oraalseks manustamiseks

Info

Publication number
EE9600050A
EE9600050A EE9600050A EE9600050A EE9600050A EE 9600050 A EE9600050 A EE 9600050A EE 9600050 A EE9600050 A EE 9600050A EE 9600050 A EE9600050 A EE 9600050A EE 9600050 A EE9600050 A EE 9600050A
Authority
EE
Estonia
Prior art keywords
quinolones
tablet
preparation
compositions containing
oral
Prior art date
Application number
EE9600050A
Other languages
English (en)
Estonian (et)
Inventor
Gousset Gabriel
Riviere Philippe
Original Assignee
Rhone- Dpc Europe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone- Dpc Europe filed Critical Rhone- Dpc Europe
Publication of EE9600050A publication Critical patent/EE9600050A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EE9600050A 1993-10-21 1994-10-19 Meetod kinoloone sisaldavate oraalsete kompositsioonide valmistamiseks ja tablett kinoloonide oraalseks manustamiseks EE9600050A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9312550A FR2711524B1 (fr) 1993-10-21 1993-10-21 Procédé de préparation de compositions orales contenant des quinolones.
PCT/FR1994/001212 WO1995011023A1 (fr) 1993-10-21 1994-10-19 Procede de preparation de compositions orales contenant des quinolones

Publications (1)

Publication Number Publication Date
EE9600050A true EE9600050A (et) 1996-10-15

Family

ID=9452072

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600050A EE9600050A (et) 1993-10-21 1994-10-19 Meetod kinoloone sisaldavate oraalsete kompositsioonide valmistamiseks ja tablett kinoloonide oraalseks manustamiseks

Country Status (30)

Country Link
US (1) US5840333A (el)
EP (1) EP0724442A1 (el)
AT (1) ATA905894A (el)
AU (1) AU7997094A (el)
BE (1) BE1007326A3 (el)
CA (1) CA2174444A1 (el)
CH (1) CH686555A5 (el)
CO (1) CO4180603A1 (el)
CZ (1) CZ113696A3 (el)
DZ (1) DZ1818A1 (el)
EE (1) EE9600050A (el)
ES (1) ES2126474B1 (el)
FI (1) FI961717L (el)
FR (1) FR2711524B1 (el)
GB (1) GB2297908B (el)
GR (1) GR1002181B (el)
HU (1) HUT74181A (el)
IE (1) IE940838A1 (el)
IT (1) IT1270672B (el)
LU (1) LU88724A1 (el)
MA (1) MA23331A1 (el)
NO (1) NO961429D0 (el)
NZ (1) NZ274874A (el)
OA (1) OA10282A (el)
PL (1) PL314005A1 (el)
SG (1) SG52202A1 (el)
SK (1) SK50596A3 (el)
TN (1) TNSN94110A1 (el)
WO (2) WO1995011022A1 (el)
ZA (1) ZA948175B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN186245B (el) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DK1083885T3 (da) * 1998-06-11 2007-02-26 Pharmacia & Upjohn Co Llc Delavirdintabletformulering
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
PL1776109T3 (pl) 2004-08-13 2009-06-30 Schering Plough Ltd Farmaceutyczna formulacja zawierająca antybiotyk, triazol i kortykosteroid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions
JPH10175936A (ja) * 1996-12-17 1998-06-30 Kao Corp 新規アミドアミノポリカルボン酸又はその塩、及びそれを含有する洗浄剤組成物

Also Published As

Publication number Publication date
SK50596A3 (en) 1997-02-05
CH686555A5 (fr) 1996-04-30
ITMI942130A1 (it) 1996-04-19
ITMI942130A0 (it) 1994-10-19
HUT74181A (en) 1996-11-28
FI961717A0 (fi) 1996-04-19
LU88724A1 (fr) 1996-08-23
CO4180603A1 (es) 1995-06-07
ES2126474A1 (es) 1999-03-16
SG52202A1 (en) 1998-09-28
FR2711524B1 (fr) 1995-11-24
FI961717A7 (fi) 1996-04-19
ZA948175B (en) 1995-06-08
NO961429L (no) 1996-04-11
WO1995011023A1 (fr) 1995-04-27
PL314005A1 (en) 1996-08-05
CA2174444A1 (fr) 1995-04-27
GR1002181B (en) 1996-03-12
MA23331A1 (fr) 1995-04-01
FR2711524A1 (fr) 1995-05-05
NO961429D0 (no) 1996-04-11
BE1007326A3 (fr) 1995-05-16
US5840333A (en) 1998-11-24
ATA905894A (de) 2000-06-15
GB2297908A (en) 1996-08-21
WO1995011022A1 (fr) 1995-04-27
DZ1818A1 (fr) 2002-02-17
ES2126474B1 (es) 1999-11-16
TNSN94110A1 (fr) 1995-09-21
GB2297908B (en) 1997-12-10
IE940838A1 (en) 1995-05-03
OA10282A (fr) 1997-10-07
GB9608316D0 (en) 1996-06-26
AU7997094A (en) 1995-05-08
EP0724442A1 (fr) 1996-08-07
FI961717L (fi) 1996-04-19
IT1270672B (it) 1997-05-07
NZ274874A (en) 1997-10-24
HU9601041D0 (en) 1996-06-28
CZ113696A3 (en) 1996-07-17

Similar Documents

Publication Publication Date Title
HU9401844D0 (en) Isatin derivatives process for the preparation thereof and pharmaceutical compositions comprising the same
IL82911A (en) Pharmaceutical composition comprising omeprazole for oral use
AU5157590A (en) Pharmaceutical compositions for oral administration
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
FI955310L (fi) Farmaseuttinen koostumus flavonoidien antamiseksi oraalisesti
ZA905861B (en) Pharmaceutical composition for oral administration containing nac
HU9700039D0 (en) New oral pharmaceutical formulation containing magnesium salt of omeprazole
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
NZ228098A (en) Quinoline derivatives and pharmaceutical compositions
EP0448091A3 (en) Pharmaceutical composition containing slightly water-soluble drug
FI910088A7 (fi) Oraalinen farmaseuttinen koostumus
HU896479D0 (en) Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof
HU896612D0 (en) Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof
IL100927A0 (en) Pharmaceutical compositions containing fused tetrahydropyridine derivatives and their manufacture
EE9400257A (et) Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
HUT67287A (en) Piperazynil camphor derivatives and pharmaceutical compositions containing them
ITMI932014A0 (it) Composizioni farmaceutiche orali effervescenti contenenti estrone
IL102116A (en) Hetaryloxy-beta-carboline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
PT87679A (pt) A process for the preparation of 2-methoxymethyl-penem derivatives and of pharmaceutical compositions containing the same
ZA933638B (en) Heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them
AU2798689A (en) Oral dosage units for pharmaceuticals and their use and preparation
FI940031L (fi) Uusia 2-syaani-3-hydroksipropenamidijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö lääkkeinä ja niitä sisältävät farmaseuttiset koostumukset